This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) inched 0.19% higher to $152.16 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.31% to 3,946.56 and Dow Jones Industrial Average falling 0.02% to 33,546.32. AbbVie Inc. closed $23.75 below its 52-week high ($175.91), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Thursday, as Pfizer Inc. (PFE) rose 0.58% to $48.33, Eli Lilly & Co. (LLY) rose 2.22% to $360.77, and AstraZeneca PLC ADR (AZN.LN) rose 0.41% to $64.06. Trading volume (4.9 M) remained 860,777 below its 50-day average volume of 5.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 17, 2022.
(END) Dow Jones Newswires
November 17, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.